While analyzing the genetic basis of MPNs, it was determined that more than 90% of PV patients carry the JAK2 p.V617F mutation; however, around 2% of PV patients do not have JAK2 p.V617F, but insertions and deletions in exon 12 [7,8,9]. The gene discussed is JAK2; the disease is acquired polycythemia vera.